Related Experiment Videos
In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid
Summary
Ascorbic acid, an antioxidant, stabilizes technetium-99m bone agents by preventing oxidation. This method ensures radiopharmaceutical stability without affecting biodistribution, crucial for accurate diagnostic imaging.
Area of Science:
- Radiopharmaceutical Chemistry
- Nuclear Medicine
- Biochemistry
Background:
- Oxidants in technetium-99m pertechnetate and oxygen in diagnostic kits compromise radiopharmaceutical stability.
- Low Sn(II) concentrations in kits exacerbate instability, leading to potential imaging inaccuracies.
Purpose of the Study:
- To evaluate ascorbic acid as an antioxidant for stabilizing low-Sn(II) bone agents.
- To assess the in vitro and in vivo stability of 99mTc-labeled disodium etidronate with ascorbic acid.
Main Methods:
- In vitro stability assessed using instant thin-layer chromatography with high-activity 99mTc generators.
- In vivo distribution studies conducted in guinea pigs.
Main Results:
- Ascorbic acid ensured in vitro stability, with <2% free 99mTc pertechnetate at 24 hr.
- Animal studies showed no altered distribution of the bone agent or ascorbic acid.
Conclusions:
- Ascorbic acid effectively stabilizes 99mTc bone agents without interfering with biodistribution.
- It acts as a noncomplexing stabilizer, enhancing radiopharmaceutical reliability for diagnostic imaging.